Sofinnova Investments, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$26,261,000
+40.5%
245,182
+34.8%
1.53%
+38.6%
Q3 2021$18,697,000
+152.6%
181,860
+91.7%
1.11%
+137.0%
Q2 2020$7,401,000
+100.6%
94,891
+50.4%
0.47%
+37.0%
Q1 2020$3,690,000
-35.9%
63,100
-12.2%
0.34%
-38.6%
Q1 2019$5,753,000
+43.5%
71,866
+40.0%
0.56%
+55.5%
Q3 2018$4,008,000
-37.9%
51,339
-49.5%
0.36%
-13.3%
Q2 2018$6,456,000101,6990.41%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders